Cubicin(R) for Complicated Post-surgical Wound Infections

NCT00651131 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

69

Enrollment

INDUSTRY

Sponsor class

Stopped terminated due to slow enrollment

Conditions

Wound Infections

Interventions

DRUG: daptomycin

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)